GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $218,000 | -13.5% | 4,647 | -20.5% | 0.02% | -29.0% |
| Q2 2017 | $252,000 | +2.4% | 5,842 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $246,000 | +15.5% | 5,842 | +5.4% | 0.03% | +10.7% |
| Q4 2016 | $213,000 | -9.0% | 5,542 | +2.1% | 0.03% | -12.5% |
| Q3 2016 | $234,000 | -6.8% | 5,427 | -10.0% | 0.03% | -3.0% |
| Q2 2015 | $251,000 | -10.4% | 6,027 | -0.8% | 0.03% | -15.4% |
| Q1 2015 | $280,000 | +21.7% | 6,077 | +12.6% | 0.04% | +30.0% |
| Q4 2014 | $230,000 | -23.1% | 5,397 | -17.2% | 0.03% | -26.8% |
| Q3 2014 | $299,000 | -20.5% | 6,517 | -7.1% | 0.04% | -21.2% |
| Q2 2014 | $376,000 | +3.3% | 7,017 | +2.9% | 0.05% | 0.0% |
| Q1 2014 | $364,000 | -0.8% | 6,817 | -0.7% | 0.05% | -5.5% |
| Q4 2013 | $367,000 | +6.4% | 6,867 | 0.0% | 0.06% | -1.8% |
| Q3 2013 | $345,000 | +4.9% | 6,867 | +4.1% | 0.06% | 0.0% |
| Q2 2013 | $329,000 | – | 6,597 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |